Conduite à tenir devant un nodule thyroïdien isolé ou au sein d’un goître multi- hétéro-nodulaire. Quand on ne dispose pas de scintigraphie thyroïdienne (Tahiti) . CAT DEVANT UN NODULE THYROIDIEN PowerPoint Presentation, PPT – DocSlides- A. HMRUC. Le nodule. thyroïdien est très fréquent. Le cancer. an isolated thyroid nodule] Conduite à tenir devant un nodule thyroïdien isolé. Le nodule thyroïdien constitue la pathologie la plus fréquente des thyroïdies.

Author: Voodoozahn Mezicage
Country: Iraq
Language: English (Spanish)
Genre: Automotive
Published (Last): 26 April 2005
Pages: 209
PDF File Size: 5.92 Mb
ePub File Size: 18.68 Mb
ISBN: 346-1-88683-208-6
Downloads: 61741
Price: Free* [*Free Regsitration Required]
Uploader: Kazrazilkree

Updating the surgical management of peritoneal carcinomatosis in patients with neuroendocrine tumors. Characteristics and treatment of patients with G3 gastroenteropancreatic neuroendocrine neoplasms. Am J Surg Pathol.

Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors. Bilan initial et surveillance: Int J Biol Markers. Clin Cancer Res ; O6-Methylguanine-DNA methyltransferase status in neuroendocrine tumours: Somatuline LP 60, 90 et mg: J Interferon Cytokine Res ; TNM staging of foregut neuro endocrine tumors: WHO classification of tumours of the digestive system. Diagnosis and Prognostic Stratification.

Streptozocin-based chemotherapy is not history in neuroendocrine tumours. Metachronous hormonal syndromes in patients with pancreatic neuroendocrine tumors: Publishing your article with us has many benefits, such as having access to a personal dashboard: The doxorubicin-streptozotocin combination for the treatment of advanced well-differentiated pancreatic endocrine carcinoma; a judicious option?



Antonodimitrakis P et al. A thyroid nodule is the most frequent of thyroid pathologies, it includes hot and cold nodules. Username Password I forgot my password.

Two-step surgery for synchronous bilobar liver metastases from digestive endocrine tumors: La classification OMS des TNE digestives ne prenait pas en compte ces tumeurs, mais la nouvelle classification les inclut annexe 1.

Br J Cancer ; J Clin Endocrinol Metab. Analysis of the NCDB.

Médecine Nucléaire

Intervention in gastro-enteropancreatic neuroendocrine tumours. DTIC therapy in patients with malignant intraabdominal neuroendocrine tumors. Are capecitabine and oxaliplatin XELOX suitable treatments for progressing low-grade and high-grade neuroendocrine tumours? Investigation et prise en charge du nodule pulmonaire solitaire dans un environnement multidisciplinaire John O.

Read our full Security, Privacy, and Copyright Policies. Treatment of metastasized midgut carcinoids with dacarbazine. Most Cited Articles The most cited articles published sinceextracted from Scopus. The diagnostic approach for a thyroid nodule rests on the clinical examination which constitutes the first step in evaluating this type of nodule, the paraclinical assessment conducted using hormone assays, aspiration cytology, ultrasound, and kn.

  JBL 4411 PDF

World J Surg ;37 7: TNE de sites rares ou inhabituels 2.

Nodule thyroïdien.

New treatment strategies in advanced neuroendocrine tumours. Am J Gastroenterol ; Efficacy of everolimus in patients with metastatic insulinoma and refractory hypoglycemia. The contents of this website are the sole responsibility of K4Health.

This free service is available to anyone who has published and whose publication is in Scopus. Delivery of Health Care. Comment citer ce chapitre?

New treatment options with cytotoxic agents in neuroendocrine tumours. CiteScore values are based on citation counts in a given year e.

TNE de primitif inconnu. Clinical effect of temozolomide-based chemotherapy in poorly differentiated endocrine carcinoma after progression on first-line chemotherapy. New insights and treatment implications. Frequency and characterization of gastro-entero-pancreatic neuroendocrine tumor patients with high-grade of uptake at somatostatin receptor scintigraphy.

MGMT expression predicts response to temozolomide in pancreatic neuroendocrine tumors.